Sign up to save your podcasts
Or
Share ACCEL Lite: Omecamtiv Mecarbil and EF in the GALACTIC-HF Trial
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ACCEL Lite: Omecamtiv Mecarbil and EF in the GALACTIC-HF Trial
In this interview, Michelle O’Donoghue, MD, FACC; John Teerlink, MD, FACC; and Jeffrey Hsu, MD, PhD, discuss the effect of ejection fraction on clinical outcomes in patients treated with omecamtiv mecarbil in the GALACTIC-HF trial. Like what you hear? Get 20 episodes a month with CME/MOC credit at www.acc.org/ACCEL.
View all episodes
By American College of Cardiology
3.7
5353 ratings
In this interview, Michelle O’Donoghue, MD, FACC; John Teerlink, MD, FACC; and Jeffrey Hsu, MD, PhD, discuss the effect of ejection fraction on clinical outcomes in patients treated with omecamtiv mecarbil in the GALACTIC-HF trial. Like what you hear? Get 20 episodes a month with CME/MOC credit at www.acc.org/ACCEL.
More shows like ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
View all
JAMA Editors' Summary
131 Listeners
NEJM This Week
323 Listeners
JACC Podcast
160 Listeners
This Week in Cardiology
863 Listeners
JAMA Clinical Reviews
494 Listeners
Mayo Clinic Talks
274 Listeners
The Curbsiders Internal Medicine Podcast
3,319 Listeners
JAMA Medical News
86 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
135 Listeners
Core IM | Internal Medicine Podcast
1,084 Listeners
ACC CardiaCast
39 Listeners
Annals On Call Podcast
186 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
351 Listeners
Cardionerds: A Cardiology Podcast
423 Listeners
Mayo Clinic Cardiovascular CME
34 Listeners